1. Home
  2. ETON vs FSBW Comparison

ETON vs FSBW Comparison

Compare ETON & FSBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETON
  • FSBW
  • Stock Information
  • Founded
  • ETON 2017
  • FSBW 1936
  • Country
  • ETON United States
  • FSBW United States
  • Employees
  • ETON N/A
  • FSBW N/A
  • Industry
  • ETON Biotechnology: Pharmaceutical Preparations
  • FSBW Banks
  • Sector
  • ETON Health Care
  • FSBW Finance
  • Exchange
  • ETON Nasdaq
  • FSBW Nasdaq
  • Market Cap
  • ETON 329.8M
  • FSBW 318.4M
  • IPO Year
  • ETON 2018
  • FSBW 2012
  • Fundamental
  • Price
  • ETON $14.51
  • FSBW $38.25
  • Analyst Decision
  • ETON Strong Buy
  • FSBW Hold
  • Analyst Count
  • ETON 3
  • FSBW 1
  • Target Price
  • ETON $24.00
  • FSBW $44.00
  • AVG Volume (30 Days)
  • ETON 330.6K
  • FSBW 15.2K
  • Earning Date
  • ETON 03-13-2025
  • FSBW 01-21-2025
  • Dividend Yield
  • ETON N/A
  • FSBW 2.82%
  • EPS Growth
  • ETON N/A
  • FSBW N/A
  • EPS
  • ETON N/A
  • FSBW 4.36
  • Revenue
  • ETON $34,677,000.00
  • FSBW $139,150,000.00
  • Revenue This Year
  • ETON $22.19
  • FSBW N/A
  • Revenue Next Year
  • ETON $110.87
  • FSBW $6.31
  • P/E Ratio
  • ETON N/A
  • FSBW $8.77
  • Revenue Growth
  • ETON 5.64
  • FSBW 0.09
  • 52 Week Low
  • ETON $3.03
  • FSBW $30.64
  • 52 Week High
  • ETON $18.41
  • FSBW $49.15
  • Technical
  • Relative Strength Index (RSI)
  • ETON 41.72
  • FSBW 38.41
  • Support Level
  • ETON $14.18
  • FSBW $38.50
  • Resistance Level
  • ETON $17.13
  • FSBW $40.57
  • Average True Range (ATR)
  • ETON 1.03
  • FSBW 0.92
  • MACD
  • ETON -0.50
  • FSBW -0.09
  • Stochastic Oscillator
  • ETON 7.80
  • FSBW 0.00

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking, and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

Share on Social Networks: